These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32364412)

  • 1. Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R4.
    Zhen Z; Zhu J; Wang J; Lu S; Sun F; Huang J; Sun X
    Pediatr Hematol Oncol; 2020 Sep; 37(6):489-499. PubMed ID: 32364412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal dosage of rituximab for children with Burkitt lymphoma.
    Huang S; Jin L; Yang J; Zhang M; Zhang Y; Peng Y; Duan Y; Zheng H
    Ann Hematol; 2024 Mar; 103(3):893-903. PubMed ID: 38091052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term clinical outcome of children and adolescents with Burkitt's lymphoma treated with rituximab combined with modified NHL-BFM-90 regimen].
    Li YX; Yin QS; Ai H; Mi RH; Zhang LN; Li YF; Wei XD; Song YP
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(8):605-610. PubMed ID: 30818930
    [No Abstract]   [Full Text] [Related]  

  • 4. [Outcome of children and adolescents with Burkitt lymphoma and diffuse large B cell lymphoma treated with a modified NHL-BFM-90 protocol].
    Sun XF; Zhen ZJ; Xia Y; Lin SX; Zhu J; Wang J; Lu SY; Sun FF; Chen Y; Zhang F; Cai RQ; Li PF
    Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1032-7. PubMed ID: 24369160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
    Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
    Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and prognosis of children with Burkitt's lymphoma: an analysis of 62 cases].
    Wang YC; DU WC; Yin CY; Gong X; Li YF
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):561-565. PubMed ID: 35644197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in India.
    Srinivasan S; Roy Moulik N; Kc A; Narula G; Sankaran H; Prasad M; Dhamne C; Cheriyalinkal Parambil B; Shah S; Shet T; Sridhar E; Gujral S; Banavali S
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28682. PubMed ID: 32865865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and prognostic analysis of 186 children with Burkitt's lymphoma].
    Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
    Zhonghua Er Ke Za Zhi; 2018 Aug; 56(8):605-610. PubMed ID: 30078243
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
    Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
    Rigaud C; Auperin A; Jourdain A; Haouy S; Couec ML; Aladjidi N; Gandemer V; Lambliotte A; Plat G; Landman-Parker J; Michon J; Leblanc T; Patte C; Minard-Colin V
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27873. PubMed ID: 31207026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
    Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
    Barnes JA; Lacasce AS; Feng Y; Toomey CE; Neuberg D; Michaelson JS; Hochberg EP; Abramson JS
    Ann Oncol; 2011 Aug; 22(8):1859-64. PubMed ID: 21339382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
    Zhu KY; Song KW; Connors JM; Leitch H; Barnett MJ; Ramadan K; Slack GW; Abou Mourad Y; Forrest DL; Hogge DE; Nantel SH; Narayanan S; Nevill TJ; Power MM; Sanford DS; Sutherland HJ; Tucker T; Toze CL; Sehn LH; Broady R; Gerrie AS
    Br J Haematol; 2018 Jun; 181(6):782-790. PubMed ID: 29741758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy.
    Woessmann W; Zimmermann M; Meinhardt A; Müller S; Hauch H; Knörr F; Oschlies I; Klapper W; Niggli F; Kabickova E; Attarbaschi A; Reiter A; Burkhardt B
    Blood; 2020 Apr; 135(14):1124-1132. PubMed ID: 31961927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
    Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.
    Cairo MS; Sposto R; Perkins SL; Meadows AT; Hoover-Regan ML; Anderson JR; Siegel SE; Lones MA; Tedeschi-Blok N; Kadin ME; Kjeldsberg CR; Wilson JF; Sanger W; Morris E; Krailo MD; Finlay JL
    Br J Haematol; 2003 Feb; 120(4):660-70. PubMed ID: 12588354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy for Burkitt's lymphoma according to the BL-M-04 protocol: 12-year experience].
    Baryakh EA; Tyurina NG; Vorobyev VI; Gemdzhyan EG; Mangasarova YK; Klyasova GA; Kovrigina AM; Obukhova TN; Zvonkov EE; Vernyuk MA; Chervontseva AM; Polyakov YY; Misyurina АЕ; Valiev TT; Zherebtsova VA; Magomedova AU; Galstyan GM; Yatskov KV; Nesterova ES; Vorobyev AI; Kravchenko SK
    Ter Arkh; 2015; 87(7):4-14. PubMed ID: 26390720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
    Mottl H; Bajciova V; Nemec J; Al Shemmari S; Al Awadi S
    Pediatr Hematol Oncol; 2003 Mar; 20(2):103-10. PubMed ID: 12554521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.